查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1947848

体外诊断（IVD）契约製造市场分析及至2035年预测：按类型、产品、服务、技术、组件、应用、最终用户、流程和设备划分

IVD Contract Manufacturing Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Process, Device
出版日期: | 出版商: Global Insight Services | 英文 313 Pages | 商品交期: 3-5个工作天内

价格
简介目录

体外诊断（IVD）契约製造市场预计将从2024年的188亿美元成长到2034年的549亿美元，复合年增长率约为11%。 IVD契约製造市场涵盖了为原始设备製造商（OEM）生产体外诊断医疗设备的专业公司所提供的服务。这些製造商在产品开发、法规遵循和可扩展生产方面拥有丰富的专业知识。随着对个人化医疗和就地检验需求的成长，该市场持续扩张。诊断领域对成本效益、品质保证和技术进步的关注正在推动市场成长，使其成为医疗保健供应链的关键组成部分。

体外诊断（IVD）契约製造市场正经历强劲成长，这主要得益于市场对经济高效且扩充性的诊断解决方案日益增长的需求。试剂和耗材细分市场是成长最快的子细分市场，这主要归功于其在诊断分析和测试中的关键作用。生物技术的进步和慢性病盛行率的上升进一步推动了该细分市场的成长。仪器细分市场紧随其后，专注于能够提高实验室效率和准确性的自动化和高通量系统。分子诊断已成为领先的子细分市场，这反映了其在个人化医疗和传染病检查中的重要性。免疫检测细分市场也展现出良好的成长前景，这得益于其在各个诊断领域的广泛应用。将生产流程外包给专业契约製造製造商的趋势正在加速发展，这带来了柔软性和成本节约。这些趋势凸显了市场的动态特性，并为体外诊断契约製造领域的相关人员带来了盈利的机会。

市场区隔
类型 试剂、试剂盒、设备、耗材、软体
产品 临床化学、分子诊断、免疫检测、血液学、微生物学、凝血
服务 契约製造、检测方法开发、分析服务、法规支援、物流
科技 聚合酶炼式反应（PCR）、次世代定序（NGS）、酵素连结免疫吸附试验（ELISA）、质谱分析、流式细胞技术
成分 抗体、核酸、酵素、缓衝液、稳定剂
目的 感染疾病、癌症、心臟病学、糖尿病、肾臟病学
最终用户 医院、诊断检查室、研究机构、生物製药公司
过程 配製、冷冻干燥、填充、包装、贴标
装置 桌上型、可携式、手持式、全自动、半自动

在体外诊断契约製造市场，现有企业凭藉创新的定价策略和突破性的产品推出，占据了大部分市场份额。该市场的特点是竞争性定价和策略性产品推出之间动态的相互作用，不断重塑市场动态。随着各公司努力实现差异化，对品质和创新的关注仍然至关重要。对客製化解决方案和最尖端科技整合的需求进一步加剧了这种竞争态势，而这些对于维持市场主导地位至关重要。竞争标竿研究揭示了主要产业参与者之间的激烈竞争。策略联盟和併购正在重塑竞争格局，而监管的影响，尤其是在北美和欧洲，对于决定市场走向至关重要，因为它决定了合规性和品质标准。儘管这些监管带来了挑战，但它们也提供了一个结构化的框架，促进了创新并确保了市场稳定。我们的市场分析强调了了解法规环境的重要性，以便应对复杂的局面并有效地掌握新的机会。

主要趋势和驱动因素：

体外诊断（IVD）契约製造市场正经历强劲成长，这主要得益于几个关键的市场趋势和驱动因素。慢性病和感染疾病的日益增加是关键驱动因素，这催生了对先进诊断解决方案的需求。这种需求推动了对高效且扩充性的生产流程的迫切需要，使得契约製造成为许多公司的策略选择。另一个趋势是诊断设备的快速技术进步，这需要专业的製造能力。这些进步正在推动创新，并为契约製造製造商提供尖端解决方案创造了机会。此外，对个人化医疗的日益重视也在影响着市场，要求製造商生产满足特定患者需求的客製化诊断试剂盒。法规遵循和品质保证也是关键驱动因素。随着监管标准的日益严格，企业正在转向拥有成熟合规经验的契约製造製造商。此外，对成本效益和更快上市时间的需求也是外包生产流程的强大驱动力。这些趋势共同为体外诊断契约製造市场的成长创造了沃土。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 试剂
    • 成套工具
    • 装置
    • 消耗品
    • 软体
  • 市场规模及预测：依产品划分
    • 临床化学
    • 分子诊断
    • 免疫检测
    • 血液学
    • 微生物学
    • 凝血
  • 市场规模及预测：依服务划分
    • 契约製造
    • 检测方法开发
    • 分析服务
    • 监理合规支持
    • 后勤
  • 市场规模及预测：依技术划分
    • PCR
    • 次世代定序（NGS）
    • ELISA
    • 质谱分析
    • 流式细胞技术
  • 市场规模及预测：依组件划分
    • 抗体
    • 核酸
    • 酵素
    • 缓衝溶液
    • 稳定器
  • 市场规模及预测：依应用领域划分
    • 感染疾病
    • 癌症
    • 心臟病学
    • 糖尿病
    • 肾臟病学
  • 市场规模及预测：依最终用户划分
    • 医院
    • 诊断检查室
    • 研究所
    • 生物製药公司
  • 市场规模及预测：依製程划分
    • 配方
    • 冷冻干燥
    • 填充
    • 包装
    • 标籤
  • 市场规模及预测：依设备划分
    • 桌面型
    • 可携式的
    • 手持式
    • 自动的
    • 半自动

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • Alere
  • Bio-Techne
  • Bio-Rad Laboratories
  • Dia Sorin
  • ELITech Group
  • Fujirebio
  • Grifols
  • Hologic
  • Kreatech Diagnostics
  • Luminex Corporation
  • Meridian Bioscience
  • Ortho Clinical Diagnostics
  • Perkin Elmer
  • Quidel Corporation
  • Randox Laboratories
  • Roche Diagnostics
  • Sekisui Diagnostics
  • Sysmex Corporation
  • Thermo Fisher Scientific
  • Werfen

第九章：关于我们

简介目录
Product Code: GIS24908

IVD Contract Manufacturing Market is anticipated to expand from $18.8 billion in 2024 to $54.9 billion by 2034, growing at a CAGR of approximately 11%. The IVD Contract Manufacturing Market encompasses services provided by specialized firms to produce in vitro diagnostic devices for OEMs. These manufacturers offer expertise in product development, regulatory compliance, and scalable production. As demand for personalized medicine and point-of-care testing rises, the market is expanding. Emphasis on cost-efficiency, quality assurance, and technological advancements in diagnostics propels growth, making it a crucial component in the healthcare supply chain.

The IVD Contract Manufacturing Market is experiencing robust growth, propelled by the increasing demand for cost-effective and scalable diagnostic solutions. The reagents and consumables segment is the top-performing sub-segment, driven by their essential role in diagnostic assays and tests. This segment's growth is further bolstered by advancements in biotechnology and the rising prevalence of chronic diseases. The instruments segment follows closely, with a focus on automated and high-throughput systems that enhance laboratory efficiency and accuracy. Molecular diagnostics emerges as a significant sub-segment, reflecting its critical importance in personalized medicine and infectious disease testing. The immunoassay segment also shows promising growth, supported by its widespread application in various diagnostic fields. The trend towards outsourcing manufacturing processes to specialized contract manufacturers is gaining momentum, offering flexibility and cost savings. These developments underscore the market's dynamic nature and highlight lucrative opportunities for stakeholders in the IVD contract manufacturing landscape.

Market Segmentation
TypeReagents, Kits, Instruments, Consumables, Software
ProductClinical Chemistry, Molecular Diagnostics, Immunoassays, Hematology, Microbiology, Coagulation
ServicesCustom Manufacturing, Assay Development, Analytical Services, Regulatory Support, Logistics
TechnologyPCR, NGS, ELISA, Mass Spectrometry, Flow Cytometry
ComponentAntibodies, Nucleic Acids, Enzymes, Buffers, Stabilizers
ApplicationInfectious Diseases, Cancer, Cardiology, Diabetes, Nephrology
End UserHospitals, Diagnostic Laboratories, Research Institutes, Biopharmaceutical Companies
ProcessFormulation, Lyophilization, Filling, Packaging, Labeling
DeviceBenchtop, Portable, Handheld, Automated, Semi-automated

In the IVD Contract Manufacturing Market, market share is predominantly held by established players, driven by innovative pricing strategies and the introduction of groundbreaking products. The landscape is characterized by a dynamic interplay of competitive pricing and strategic product launches, which continuously reshape market dynamics. As companies strive to differentiate themselves, the focus on quality and technological advancements remains paramount. This competitive spirit is further fueled by the demand for customized solutions and the integration of cutting-edge technologies, which are pivotal in maintaining market leadership. Competition benchmarking reveals a robust rivalry among key industry participants, with strategic partnerships and mergers shaping the competitive landscape. Regulatory influences, particularly in North America and Europe, are pivotal in defining market trajectories, as they dictate compliance and quality standards. These regulations, while challenging, also provide a structured framework that propels innovation and ensures market stability. The market analysis highlights the importance of understanding these regulatory environments to navigate the complexities and capitalize on emerging opportunities effectively.

Geographical Overview:

The IVD contract manufacturing market is witnessing robust growth across various regions, each presenting unique opportunities. North America leads the charge, driven by technological advancements and increased demand for efficient diagnostic solutions. The presence of established healthcare infrastructure and major industry players further bolsters the region's market dominance. Europe follows closely, characterized by a strong focus on innovation and regulatory compliance. The region's emphasis on quality and precision in diagnostics fosters a thriving ecosystem for IVD contract manufacturing. In Asia Pacific, rapid economic development and rising healthcare expenditures are propelling market expansion. Countries such as China and India are emerging as key players, with significant investments in healthcare infrastructure and biotechnology. Latin America and the Middle East & Africa are also showing promising growth. In Latin America, increased awareness of advanced diagnostic solutions is driving demand, while in the Middle East & Africa, government initiatives and investments in healthcare are creating new growth pockets for the IVD contract manufacturing market.

Global tariffs and geopolitical tensions are critically influencing the IVD Contract Manufacturing Market, particularly in East Asia. In Japan and South Korea, firms are navigating tariff-induced cost pressures by enhancing local production capabilities and fostering innovation in diagnostic technologies. China, amid export constraints, is accelerating its focus on self-sufficiency and indigenous manufacturing of IVD components. Taiwan, while pivotal in the supply chain, remains vulnerable to geopolitical frictions, necessitating strategic partnerships and diversification. The parent market for IVDs is robust, driven by advancements in healthcare and diagnostics. By 2035, the market is projected to experience significant growth, underpinned by technological innovation and regional collaboration. Middle East conflicts could exacerbate supply chain disruptions and elevate energy prices, influencing operational costs and market dynamics globally.

Key Trends and Drivers:

The IVD Contract Manufacturing Market is experiencing robust growth, propelled by several key trends and drivers. The increasing prevalence of chronic and infectious diseases is a significant driver, necessitating advanced diagnostic solutions. This demand fuels the need for efficient and scalable manufacturing processes, positioning contract manufacturing as a strategic choice for many companies. Another trend is the rapid technological advancements in diagnostic devices, which require specialized manufacturing capabilities. These advancements are driving innovation and creating opportunities for contract manufacturers to offer cutting-edge solutions. Furthermore, the growing emphasis on personalized medicine is influencing the market, as manufacturers need to produce customized diagnostic kits that cater to specific patient needs. Regulatory compliance and quality assurance are also critical drivers. As regulatory standards become more stringent, companies are turning to contract manufacturers with proven expertise in compliance. Additionally, cost-efficiency and the need to reduce time-to-market are compelling factors for outsourcing manufacturing processes. These dynamics create a fertile landscape for growth in the IVD Contract Manufacturing Market.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Device

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Reagents
    • 4.1.2 Kits
    • 4.1.3 Instruments
    • 4.1.4 Consumables
    • 4.1.5 Software
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Clinical Chemistry
    • 4.2.2 Molecular Diagnostics
    • 4.2.3 Immunoassays
    • 4.2.4 Hematology
    • 4.2.5 Microbiology
    • 4.2.6 Coagulation
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Custom Manufacturing
    • 4.3.2 Assay Development
    • 4.3.3 Analytical Services
    • 4.3.4 Regulatory Support
    • 4.3.5 Logistics
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 PCR
    • 4.4.2 NGS
    • 4.4.3 ELISA
    • 4.4.4 Mass Spectrometry
    • 4.4.5 Flow Cytometry
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Antibodies
    • 4.5.2 Nucleic Acids
    • 4.5.3 Enzymes
    • 4.5.4 Buffers
    • 4.5.5 Stabilizers
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Infectious Diseases
    • 4.6.2 Cancer
    • 4.6.3 Cardiology
    • 4.6.4 Diabetes
    • 4.6.5 Nephrology
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Diagnostic Laboratories
    • 4.7.3 Research Institutes
    • 4.7.4 Biopharmaceutical Companies
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Formulation
    • 4.8.2 Lyophilization
    • 4.8.3 Filling
    • 4.8.4 Packaging
    • 4.8.5 Labeling
  • 4.9 Market Size & Forecast by Device (2020-2035)
    • 4.9.1 Benchtop
    • 4.9.2 Portable
    • 4.9.3 Handheld
    • 4.9.4 Automated
    • 4.9.5 Semi-automated

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Process
      • 5.2.1.9 Device
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Process
      • 5.2.2.9 Device
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Process
      • 5.2.3.9 Device
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Process
      • 5.3.1.9 Device
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Process
      • 5.3.2.9 Device
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Process
      • 5.3.3.9 Device
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Process
      • 5.4.1.9 Device
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Process
      • 5.4.2.9 Device
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Process
      • 5.4.3.9 Device
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Process
      • 5.4.4.9 Device
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Process
      • 5.4.5.9 Device
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Process
      • 5.4.6.9 Device
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Process
      • 5.4.7.9 Device
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Process
      • 5.5.1.9 Device
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Process
      • 5.5.2.9 Device
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Process
      • 5.5.3.9 Device
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Process
      • 5.5.4.9 Device
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Process
      • 5.5.5.9 Device
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Process
      • 5.5.6.9 Device
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Process
      • 5.6.1.9 Device
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Process
      • 5.6.2.9 Device
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Process
      • 5.6.3.9 Device
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Process
      • 5.6.4.9 Device
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Process
      • 5.6.5.9 Device

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Alere
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Bio- Techne
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Bio- Rad Laboratories
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Dia Sorin
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 ELITech Group
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Fujirebio
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Grifols
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Hologic
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Kreatech Diagnostics
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Luminex Corporation
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Meridian Bioscience
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Ortho Clinical Diagnostics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Perkin Elmer
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Quidel Corporation
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Randox Laboratories
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Roche Diagnostics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Sekisui Diagnostics
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Sysmex Corporation
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Thermo Fisher Scientific
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Werfen
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us